Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Tempus | 2026 | Post-IPO Debt | Undisclosed | Chicago |
| Tempest Therapeutics | 2026 | Post-IPO Equity | Undisclosed | San Francisco |
| Aera Technology | 2026 | Venture - Series Unknown | Undisclosed | Mountain View |
| Mirum Pharmaceuticals | 2026 | Post-IPO Debt | Undisclosed | Foster City |
| Trevi Therapeutics | 2026 | Post-IPO Equity | Undisclosed | Sandy Hook |
| AviadoBio | 2026 | Grant | Undisclosed | London |
| Zenas BioPharma | 2026 | Post Ipo Equity | $100.0M | Waltham |
| Maisonette | 2026 | Series Unknown | $5.9M | Brooklyn |
| BNTO | 2026 | Series Unknown | $22.4M | Los Angeles |
| Qualified Health | 2026 | Series B | $125.0M | San Carlos |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Tempus | Post-IPO Debt | Undisclosed | Chicago, United States |
| 2 | Tempest Therapeutics | Post-IPO Equity | Undisclosed | San Francisco, United States |
| 3 | Aera Technology | Venture - Series Unknown | Undisclosed | Mountain View, United States |
| 4 | Mirum Pharmaceuticals | Post-IPO Debt | Undisclosed | Foster City, United States |
| 5 | Trevi Therapeutics | Post-IPO Equity | Undisclosed | Sandy Hook, United States |
| 6 | AviadoBio | Grant | Undisclosed | London, United Kingdom |
| 7 | Zenas BioPharma | Post Ipo Equity | $100.0M | Waltham, United States |
| 8 | Maisonette | Series Unknown | $5.9M | Brooklyn, United States |
| 9 | BNTO | Series Unknown | $22.4M | Los Angeles, United States |
| 10 | Qualified Health | Series B | $125.0M | San Carlos, United States |
Tempus develops AI-enabled precision medicine technology that supports clinical decision-making and biomedical research.
Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.
Aera Technology is the Decision Intelligence company that digitizes, augments, and automates decision making in real time.
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.
AviadoBio transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.
Maisonette is a children’s clothing and lifestyle e-commerce site.
BNTO is an AI-powered subscription platform that offers personalized fashion experiences by integrating new purchases, rentals, and resales.
Qualified Health develops artificial intelligence tools that support clinical decision-making and patient care management.
Namespace accelerates the development workflow of fast-moving software engineering teams.
CuspAI is an AI company that discovers new materials to solve problems and enable human progress.
CoreStory provides a platform that helps enterprises understand their legacy code.
Uniphore is a business-software company that provides a secure AI platform that deploys agentic AI across every enterprise function.
QuoteWell is a digital-first platform that meets the demands of the contemporary insurance sector.
Autonomous AI agents for Security Risk and Compliance
Augment Markets is a pre-IPO marketplace that enables investors to buy and sell shares in private companies.
Flox offers developers, platform engineers, and operators reproducible environments that span the enterprise SDLC. Bringing Nix to Work!
Factory provides AI software agents automating complex development tasks and workflows.
Brale provides a platform for issuing and managing stablecoins on multiple blockchain networks.
Clockwork Systems is a technology company that offers network-software solutions designed for high-performance, time-sensitive workloads.
Perplexity is an AI-powered answer engine designed to provide accurate, real-time responses to user queries.
Strive Health is a value-based kidney care provider with an integrated system supporting the journey of individuals with kidney disease.
Mojo develops high-performance micro-LED display technology with proprietary full-color quantum-dot technology with superior performance
Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.
New Enterprise Associates has invested in 461 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
New Enterprise Associates's top investment sectors include Artificial Intelligence (AI), Health Care, Information Technology, Biotechnology, Medical. The firm invests across 48 different industry categories.
Among tracked funding rounds, Strive Health received $300.0M in a Series D round. New Enterprise Associates's total known invested capital is $21.4B.
New Enterprise Associates's average investment size is $66.5M across its portfolio of 461 companies.
Recent New Enterprise Associates portfolio additions include Tempus, Tempest Therapeutics, Aera Technology, Mirum Pharmaceuticals, Trevi Therapeutics. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors